Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)Inge Winter-van Rossum, Peter Haddad, Mark Weiser et al.|The Lancet Psychiatry|2023Cited by 48
High unrecognized SARS-CoV-2 exposure of newly admitted and hospitalized psychiatric patientsKawtar El Abdellati, Marion Leboyer, Steven D.E. Fried et al.|Brain Behavior and Immunity|2023Cited by 5
Dynamic immune dysregulation in severe mental illness: Exaggerated innate and attenuated adaptive immune responses following SARS-CoV-2 vaccinationTim Rietberg, Livia De Picker, Kawtar El Abdellati et al.|Brain Behavior & Immunity - Health|2025Cited by 0